Join to View Full Profile
300 Pasteur Dr# StanfordStanford, CA 94305
Phone+1 650-723-4000
Dr. Shu is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
New York Presbyterian Hospital (Cornell Campus)Fellowship, Endocrinology, Diabetes, and Metabolism, 2006 - 2009
Mass General Brigham/Brigham and Women's HospitalResidency, Internal Medicine, 2003 - 2006- New York Presbyterian Hospital (Columbia Campus)Residency, Internal Medicine, 2003 - 2006
Harvard Medical SchoolClass of 2003
Certifications & Licensure
CA State Medical License 2012 - 2025
TX State Medical License 2010 - 2024
NY State Medical License 2006 - 2011
American Board of Internal Medicine Endocrinology, Diabetes and Metabolism
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2011, 2013
Clinical Trials
- A Safety, Tolerability and Efficacy Study of TransCon hGH in Children With Growth Hormone Deficiency Start of enrollment: 2017 Nov 13
Publications & Presentations
PubMed
- 2 citationsEfficacy and Safety of TransCon PTH in Adults With Hypoparathyroidism: 52-Week Results From the Phase 3 PaTHway Trial.Bart L Clarke, Aliya A Khan, Mishaela R Rubin, Peter Schwarz, Tamara Vokes
The Journal of Clinical Endocrinology and Metabolism. 2025-03-17 - 7 citationsPalopegteriparatide Treatment Improves Renal Function in Adults with Chronic Hypoparathyroidism: 1-Year Results from the Phase 3 PaTHway Trial.Lars Rejnmark, Elvira O Gosmanova, Aliya A Khan, Noriko Makita, Yasuo Imanishi
Advances in Therapy. 2024-06-01 - 6 citationsOnce-weekly TransCon CNP (navepegritide) in children with achondroplasia (ACcomplisH): a phase 2, multicentre, randomised, double-blind, placebo-controlled, dose-escal...Ravi Savarirayan, Daniel G Hoernschemeyer, Merete Ljungberg, Yuri A Zarate, Carlos A Bacino
Eclinicalmedicine. 2023-11-01
Press Mentions
- Ascendis Pharma A/S Announces Presentations for Its Endocrinology Rare Disease Clinical Programs at Upcoming Medical ConferencesOctober 21st, 2020
- Ascendis Pharma A/S Announces Presentations for Its Endocrinology Rare Disease Clinical Programs at Upcoming Medical ConferencesOctober 21st, 2020
Ascendis Presents TransCon™ PTH Data at the American Thyroid Association Annual MeetingOctober 3rd, 2023
Professional Memberships
- Member
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
